文献速递主动脉疾病

胸腹主动脉瘤基于疾病的观察性队列研究的生存与以患者为中心的结果

Survival and patient-centered outcome in a disease-based observational cohort study of patients with thoracoabdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2019-05-27

开放、腔内和部分修复组较非手术组有3年生存获益,杂交组未见获益。

要点

  • 近半数胸腹主动脉瘤患者未接受修复,多因合并症负担重而非破裂死亡。
  • 手术组1年生存率高于非手术组,但良好结局比例显著低于生存率。
  • 开放、腔内和部分修复有3年生存获益,杂交修复未见生存获益。

核心结论

  • 在包含非手术和手术患者的胸腹主动脉瘤队列中,近半数未修复,短期死亡多因合并症而非破裂。
  • 手术在合适选择的患者中似有生存优势,但大部分患者高风险且可能无法从手术中获益。

研究设计与样本

  • 单中心基于疾病诊断代码筛选2009至2017年胸腹主动脉瘤患者,经病历和CT确认诊断。
  • 纳入标准为连续的内脏旁主动脉瘤样扩张≥3.2 cm且符合标准修复指征,排除<18岁和真菌性动脉瘤。
  • 共纳入432例患者,分为非手术组和四种手术策略:开放、分支支架腔内、杂交(髂内脏去分支后支架)和部分修复。

主要发现

  • 未手术者中65%存活至1年。
  • 开放、腔内和部分修复组较非手术组在3年内有生存获益,杂交组无生存获益。

关键数值与推荐

  • 良好结局定义为成功排除动脉瘤、无永久性器官系统功能丧失且术后恢复至术前功能状态。

临床怎么用

  • 评估胸腹主动脉瘤患者时需综合考虑合并症和基线功能状态,手术决策应权衡生存获益与良好结局概率。
  • 对高风险患者,非手术管理可能是合理选择,需告知其短期生存主要受合并症影响。

局限性

  • 单中心回顾性队列设计,存在选择偏倚和转诊偏倚可能。
  • 部分修复组中内脏旁段有意未处理,可能影响结局比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Much of the literature describing treatment for thoracoabdominal aortic aneurysm (TAAA) consists of operative series reported by centers of excellence. These studies are limited by referral and selection bias and exclude patients who are not candidates for the reported modality of repair. Little is known about the patients who are not referred or selected for repair. For those undergoing intervention, outcomes such as functional status after surgery are rarely reported. In this study, we address these gaps by reporting two primary end points: 1-year survival and a "good" outcome (defined as successful aneurysm exclusion, freedom from permanent loss of organ system function, and return to preoperative functional status after surgery) in a cohort of TAAA patients, including all nonoperative and operative patients, irrespective of treatment modality. METHODS: A single-institution database was screened by diagnosis codes for TAAA from 2009 to 2017 using the International Classification of Diseases versions 9 and 10. Diagnosis was confirmed by retrospective chart review and computed tomography findings of aneurysmal degeneration ≥3.2 cm of the paravisceral aorta in continuity with aneurysmal aorta meeting standard criteria for repair. Patients <18 years of age and those with mycotic aneurysm were excluded. Patients were either managed nonoperatively or by one of four operative strategies: (i) open; (ii) endovascular with branched endografts; (iii) hybrid, defined as iliovisceral debranching followed by endograft placement; or (iv) partial repair in which the paravisceral segment was intentionally left unaddressed. RESULTS: Among the entire cohort of 432 patients with TAAA, significant comorbidities were seen in 143 (33%). Forty-seven percent of the patients were managed nonoperatively. Of these, 65% survived to 1 year. A survival benefit was seen in the open, endovascular, and partial, but not hybrid, operative groups compared with the nonoperative group during a 3-year period. Overall 1-year survival was 81%, but only 65% had a good outcome (P = .0016). CONCLUSIONS: Nearly half of the patients in this inclusive cohort study did not undergo repair despite access to a variety of operative techniques. Many of these patients die in the short term due to high burden of comorbid disease rather than aneurysm rupture. Among those undergoing operation, a notable difference between survival and good outcome was observed. Operation appears to confer a survival advantage among appropriately selected patients with TAAA, but a large proportion are high risk and may not benefit from operative repair due to limited baseline survival and lower probability of good outcome.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kang PC, Bartek MA, Shalhub S, et al. Survival and patient-centered outcome in a disease-based observational cohort study of patients with thoracoabdominal aortic aneurysm. J Vasc Surg. 2019. PMID: 31147133. doi:10.1016/j.jvs.2019.02.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。